Bicycle Therapeutics Ownership | Who Owns Bicycle Therapeutics?
Bicycle Therapeutics Ownership Summary
Bicycle Therapeutics is owned by 0.10% institutional investors, 1.46% insiders, and 98.44% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 15.73% of BCYC shares. T. Rowe Price Health Sciences is the top mutual fund, with 1.69% of its assets in Bicycle Therapeutics shares.
BCYC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bicycle Therapeutics | 0.10% | 1.46% | 98.44% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 10.89M | 15.73% | $92.42M |
| Point72 asset management | 4.55M | 6.60% | $63.77M |
| Fcpm iii services b.v. | 3.45M | 5.00% | $48.33M |
| Westfield capital management co lp | 2.61M | 3.78% | $36.54M |
| Armistice capital | 2.20M | 3.18% | $30.74M |
| Morgan stanley | 1.23M | 2.89% | $24.93M |
| Siren | 1.84M | 2.67% | $25.75M |
| Price t rowe associates inc /md/ | 1.59M | 2.30% | $22.19M |
| Tybourne capital management (hk) | 1.27M | 1.84% | $17.77M |
| Bnp paribas asset management | 1.16M | 1.68% | $16.18M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Fcpm iii services b.v. | 3.45M | 8.16% | $48.33M |
| Tybourne capital management (hk) | 1.27M | 4.46% | $17.77M |
| Aquilo capital management | 171.69K | 2.61% | $1.46M |
| Siren | 1.84M | 1.14% | $25.75M |
| Baker bros. advisors lp | 10.89M | 1.02% | $92.42M |
| Ecor1 capital | 910.00K | 0.48% | $12.74M |
| Nan fung group | 68.94K | 0.48% | $585.33K |
| Armistice capital | 2.20M | 0.42% | $30.74M |
| Palo alto investors lp | 248.93K | 0.40% | $2.11M |
| Entrypoint capital | 43.87K | 0.26% | $614.22K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 4.55M | 0.14% | 3.66M |
| Siren | 1.84M | 1.14% | 1.84M |
| Fcpm iii services b.v. | 3.45M | 8.16% | 1.11M |
| Westfield capital management co lp | 2.61M | 0.16% | 759.39K |
| Long focus capital management | 543.09K | 0.25% | 543.09K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | - | - | -3.25M |
| Polar capital | - | - | -1.00M |
| First light asset management | - | - | -967.01K |
| Camber capital management lp | - | - | -915.00K |
| Suvretta capital management | - | - | -914.48K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Siren | 1.84M | 1.14% | 1.84M | $25.75M |
| Long focus capital management | 543.09K | 0.25% | 543.09K | $7.60M |
| Caption management | 163.08K | 0.02% | 163.08K | $2.28M |
| Entrypoint capital | 43.87K | 0.26% | 43.87K | $614.22K |
| Group one trading | 466.00 | - | 466.00 | $6.52M |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -4.00 |
| Mather group, llc. | -5.00 |
| Northwestern mutual wealth management | -5.00 |
| Caitlin john | -14.00 |
| Wells fargo & company/mn | -30.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1 | -99.00% | 68,943 | -99.84% | - | 0.00% | - | -100.00% | - | -100.00% |
| Dec 31, 2024 | 99 | -10.00% | 41,889,682 | 3.58% | 60 | 1.77% | 44 | -16.98% | 36 | 12.50% |
| Sep 30, 2024 | 110 | 1.85% | 40,440,427 | 1.84% | 58 | 1.00% | 55 | -9.84% | 32 | 28.00% |
| Jun 30, 2024 | 107 | 11.46% | 39,708,441 | 30.36% | 93 | 1.81% | 60 | 42.86% | 25 | -24.24% |
| Mar 31, 2024 | 96 | -10.28% | 30,461,275 | -2.88% | 71 | 1.14% | 42 | -25.00% | 33 | 3.13% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Health Sciences | 1.17M | 1.69% | -17.65K |
| Westfield Capital Mgt Co Sm-Cap Gr Eq | 1.00M | 1.45% | 14.32K |
| Harbor Small Cap Growth Instl | 1.00M | 1.45% | - |
| Candriam Eqs L Biotech C USD Cap | 643.68K | 0.93% | -5.19K |
| BNP Paribas Health Cr Innovtr Cl Cap | 568.23K | 0.82% | -108.78K |
| Candriam Global Equities Oncology | 492.11K | 0.71% | 125.18K |
| BNP Paribas US Small Cap Classic R | 477.48K | 0.69% | -69.83K |
| Belfius Equities Cure C Cap | 367.15K | 0.53% | -189.16K |
| MEDICAL BioHealth EUR Acc | 343.42K | 0.50% | -32.65K |
| Polar Capital Biotech S Inc | 297.67K | 0.43% | -592.95K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 02, 2025 | Young Alethia | Chief Financial Officer | Sell | $1.72K |
| Apr 03, 2025 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | $7.76K |
| Apr 02, 2025 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | $6.53K |
| Apr 02, 2025 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | $17.94K |
| Apr 03, 2025 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | $25.67K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 15 |
| 2024 Q4 | 10 | 11 |
| 2024 Q3 | - | 7 |
| 2024 Q2 | - | 7 |
| 2024 Q1 | - | 6 |
BCYC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools